References
- FerraraNHillanKJGerberHPNovotnyWDiscovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNat Rev Drug Discov2004339140015136787
- YoungRJReedMWAnti-angiogenic therapy: concept to clinicMicrocirculation201219211512522078005
- EcksteinNRöperLHaasBClinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspectiveJ Exp Clin Cancer Res2014331524502453
- EngelmanJASettlemanJAcquired resistance to tyrosine kinase inhibitors during cancer therapyCurr Opin Genet Dev200818737918325754
- GiulianoSPagèsGMechanisms of resistance to anti-angiogenesis therapiesBiochimie20139561110111923507428
- RiniBISunitinibExpert Opin Pharmacother20078142359236917927489
- BergersGHanahanDModes of resistance to anti-angiogenic therapyNat Rev Cancer20088859260318650835
- BracciRMaccaroniECascinuSTransient sunitinib resistance in gastrointestinal stromal tumorsN Engl J Med2013368212042204323697529
- ShuklaSRobeyRWBatesSEAmbudkarSVSunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2Drug Metab Dispos200937235936518971320
- DaiCLLiangYJWangYSSensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2Cancer Lett20092791748319232821
- PénzváltóZTegzeBSzászAMIdentifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell linesPLoS One201383e5950323555683
- KerbelRSInhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agentsBioessays19911331361722975
- AkiyamaKOhgaNHidaYTumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironmentAm J Pathol20121801283129322245726
- HuangLPerraultCCoelho-MartinsJInduction of acquired drug resistance in endothelial cells and its involvement in anticancer therapyJ Hematol Oncol2013614923837843
- Trochon-JosephVMartel-RenoirDMirLMEvidence of anti-angiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidinCancer Res20046462062206915026344
- JiBSHeLLiuGQReversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cellsLife Sci2005772221223215967469
- BakerEKJohnstoneRWZalcbergJREl-OstaAEpigenetic changes to the MDR1 locus in response to chemotherapeutic drugsOncogene200524548061807516091741
- ToKKPolgarOHuffLMMorisakiKBatesSEHistone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cellsMol Cancer Res20086115116418234970
- BrózikAHegedüsCErdeiZTyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?Expert Opin Drug Metab Toxicol20117562364221410427
- ZhouQLvHMazloomARXuHMa’ayanAGalloJMActivation of alternate prosurvival pathways accounts for acquired sunitinib resistance in U87MG glioma xenograftsJ Pharmacol Exp Ther2012343250951922869928
- RosenzweigSAAcquired resistance to drugs targeting receptor tyrosine kinasesBiochem Pharmacol20128381041104822227013
- HuangMShenADingJGengMMolecularly targeted cancer therapy: some lessons from the past decadeTrends Pharmacol Sci2014351415024361003
- YangJIkezoeTNishiokaCLong-term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN geneInt J Cancer2012130495996621445973
- PiscazziACostantinoEMaddalenaFActivation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell linesJ Clin Endocrinol Metab2012976E898E90622442268
- ShojaeiFLeeJHSimmonsBHHGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumorsCancer Res20107024100901010020952508
- WeltiJCGourlaouenMPowlesTFibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinibOncogene201130101183119321057538
- HidaKAkiyamaKOhgaNMaishiNHidaYTumour endothelial cells acquire drug resistance in a tumour microenvironmentJ Biochem2013153324324923293323